Trump policies, China's biotech boom are ending Europe's pharma powerhouse era
Companies have long lamented Europe’s fragmented capital markets, single-market adoption on pricing and clinical trials, and uneven reimbursement policies.
Source: Cnbc.com
Original source: https://www.cnbc.com/2026/04/11/trump-pharma-tariffs-mfn-china-europe-biotech-stocks.html